These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9067566)

  • 1. Relief of jaundice by 5-fluorouracil and folinic acid in patients with recurrent gastric cancer.
    Kajiyama Y; Tsurumaru M; Udagawa H; Tsutsumi K; Kinoshita Y; Akiyama H
    Surg Oncol; 1996 Aug; 5(4):177-81. PubMed ID: 9067566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the association of folinic acid and 5-fluorouracil alone versus folinic acid and 5-fluorouracil plus 4-epidoxorubicin in the treatment of advanced gastric carcinoma.
    Colucci G; Giotta F; Maiello E; Cifarelli RA; Leo S; Giuliani F; Pezzella G; Pedicini A; Valori V
    Am J Clin Oncol; 1995 Dec; 18(6):519-24. PubMed ID: 8526196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
    Klaassen U; Wilke H; Seeber S
    J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.
    Luo HY; Xu RH; Zhang L; Li YH; Shi YX; Lin TY; Han B; Wang F; Qiu MZ; He YJ; Guan ZZ
    Chemotherapy; 2008; 54(3):228-35. PubMed ID: 18560231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorouracil-based combinations in the treatment of metastatic breast cancer.
    Klaassen U; Wilke H; Harstrick A; Seeber S
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):31-5. PubMed ID: 9516601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation.
    Mackean MJ; Cassidy J; Jodrell DI; Paul J; Reed NS; Canney PA; Yosef H; Habeshaw T; Robertson AG; McInnes A; Twelves CJ
    Br J Cancer; 1998 May; 77(9):1480-6. PubMed ID: 9652765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancer.
    Wilke H; Korn M; Vanhöfer U; Fink U; Stahl M; Preusser P; Köhne C; Klassen U; Harstrick A; Schmoll HJ; Seeber S
    J Infus Chemother; 1996; 6(3):123-6. PubMed ID: 9229322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive evaluation of cardiotoxicity of 5-fluorouracil and low doses of folinic acid: a one-year follow-up study.
    Grandi AM; Pinotti G; Morandi E; Zanzi P; Bulgheroni P; Guasti L; Bertolini A; Venco A
    Ann Oncol; 1997 Jul; 8(7):705-8. PubMed ID: 9296228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trial with a weekly regimen of 5-FU vs 5-FU + intermediate-dose folinic acid in the treatment of advanced colo-rectal cancer.
    Martoni A; Cricca A; Guaraldi M; Covizzi M; Farris A; Pannuti F
    Ann Oncol; 1992 Jan; 3(1):87-8. PubMed ID: 1606077
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
    De Vita F; Orditura M; Matano E; Bianco R; Carlomagno C; Infusino S; Damiano V; Simeone E; Diadema MR; Lieto E; Castellano P; Pepe S; De Placido S; Galizia G; Di Martino N; Ciardiello F; Catalano G; Bianco AR
    Br J Cancer; 2005 May; 92(9):1644-9. PubMed ID: 15856038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new choleretic effect of folinic acid.
    Kajiyama Y; Tsurumaru M; Udagawa H; Tsutsumi K; Kinoshita Y; Ueno M; Akiyama H
    Hepatogastroenterology; 1998; 45(23):1442-5. PubMed ID: 9840080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, epirubicin and cisplatin (modified ECF) as adjuvant chemotherapy in resected gastric adenocarcinoma.
    Unek IT; Unek T; Oztop I; Akman T; Atilla K; Ellidokuz H; Bora S; Sarioglu S; Yilmaz U
    Chemotherapy; 2012; 58(3):233-40. PubMed ID: 22832016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.
    Ravandi F; Rytting ME; Osmon C; Braud EL; Roach RW; Edwards K; Winn R; Abbruzzese JL; Pazdur R
    Anticancer Drugs; 1999 Jul; 10(6):519-24. PubMed ID: 10885898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada.
    Maroun J; Asche C; Romeyer F; Mukherjee J; Cripps C; Oza A; Skillings J; Letarte J
    Pharmacoeconomics; 2003; 21(14):1039-51. PubMed ID: 13129416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers.
    Schulze-Bergkamen H; Zuna I; Teufel A; Stremmel W; Rudi J
    Med Oncol; 2002; 19(1):43-53. PubMed ID: 12025890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of refractory ovarian cancer with 5-fluorouracil and leucovorin.
    Préfontaine M; Donovan JT; Powell JL; Buley L
    Gynecol Oncol; 1996 May; 61(2):249-52. PubMed ID: 8626142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and toxicity of continuous infusion (6S)-folinic acid and bolus 5-fluorouracil in patients with advanced cancer.
    Newman EM; Akman SA; Harrison JS; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Somlo G; Ahn CW; Doroshow JH
    Cancer Res; 1992 May; 52(9):2408-12. PubMed ID: 1568210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European experience with irinotecan plus fluorouracil/folinic acid or mitomycin.
    Khayat D; Gil-Delgado M; Antoine EC; Coeffic D; Benhammouda A; Grapin JP; Bastian G
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):64-7. PubMed ID: 9726094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
    Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies.
    Comella P; Palmieri G; Lorusso V; Catalano G; Nicollela D; Ianniello GP; Casaretti R; Montella M; Frasci G; Perna M; Comella G
    Eur J Cancer; 1996 Sep; 32A(10):1719-26. PubMed ID: 8983280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.